Galactose, intravenous

TERMINATED · NA · Diabetic Macular Oedema

No sufficient increase in plasma osmolarity by galactose (one patient included)

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.